Published Dec 13, 2017
DePuy Synthes releases Nitinol Continuous Compression Implants to improve patient outcomes and enhance procedural efficiencies in EMEA
Solothurn, Switzerland – December 12, 2017 – DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa (EMEA). The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Foot and ankle surgery that aims to correct painful deformities, such as bunions and hammertoes, are associated with a range of potential complications due to poor stabilization of fracture and joints. Complications may result in implant failure, non-union of bones, infection, pain and the development of arthritis, leading to increased hospitalization time, re-admissions or physical therapy.
Unlike traditional foot and ankle fixation methods, DePuy Synthes Continuous Compression Implants are manufactured with a specific formulation of Nitinol, a “shape memory” metal, to continuously and dynamically keep bones compressed together throughout the healing process. This compression helps address challenges of foot and ankle procedures by reducing the risk of complications, and may allow patients to more quickly resume normal activity.2,3,4,6
To save time in the operating room, DePuy Synthes Continuous Compression Implants come ready to use, sterile and pre-loaded onto an insertion tool, removing the need to heat or freeze the implants prior to use.
“This new generation of Nitinol implants is a breakthrough due to its advancement in technology and an exciting trend for foot and ankle surgery,” said Dr. J. Kent Ellington of the OrthoCarolina Foot & Ankle Institute in Charlotte, NC, USA. “A main concern for foot and ankle surgeries is whether any implant construct used can withstand the repetitive load the lower body experiences with even limited activity and achieve reproducible healing. The Continuous Compression Implants are not only extremely simple to use, they improve time to weight bearing, provide sustained compression, offer significant strength, control rotation, ultimately promoting faster healing and a quicker recovery for patients.” 1,2,3,4
“DePuy Synthes introduction of Continuous Compression Implants to EMEA-based healthcare providers is testament to our commitment to deliver value-added innovation and improved access to tools that both simplify procedures and improve patient outcomes,” said Virve Sarja, DePuy Synthes Trauma & CMF Lead, EMEA. “These implants and single-use instruments have been shown to improve operating theatre efficiencies, reduce costs and help the patient quickly return to their normal daily activities.”
About DePuy Synthes Companies
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopaedics portfolios in the world. DePuy Synthes Companies solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information, visit www.depuysynthes.com.
Notes to the Editor
Dr. J. Kent Ellington from Charlotte, NC will dive into the science of Continuous Compression Implants, including the presentation of a new study “Radiographic Results of Nitinol Compression Staples for Hindfoot and Midfoot Arthrodeses,” during a live webinar taking place on 13 December 2017 between 18.00 -19.00 CET. Visit https://webinars.on24.com/jji/nitinol to register.
The third-party trademarks used herein are the trademarks of their respective owners. The views expressed herein are not necessarily the views of DePuy Synthes.
©DePuy Synthes 2017. All rights reserved
This publication is not intended for distribution in the USA
Registered Office: Johnson & Johnson Medical Limited, PO BOX 1988, Simpson Parkway, Livingston, West Lothian, EH54 0AB, United Kingdom. Incorporated and registered in Scotland under company number SC132162
[1] Harden JL, Hiscox JA. Cost Savings and quality improvements-single use suture instruments. Scott Med J 2006;51(3):30-33
[2] Sarchino WJ BM, McGuire S, Yoo E. Surgical Outcomes of BME SPEEDTRIAD Staple for Chevron Osteotomy. American College of Foot and Ankle Surgeons; February 27-March 2, 2017; Las Vegas, NV, USA.
[3] Budny A. Use of Speed TriadTM and Speed ArcTM Shape Memory Implants for Fixation of Austin and Akin Osteotomies.BME (BioMedical Enterprises, Inc.);2016.
[4] Fishco W. Speed Triad Staple Fixation for Austin Osteotomy in Hallux Valgus Correction BME (BioMedical Enterprises, Inc.); 2016
[5] Belatti DA, Phisitkul P. Economic burden of foot and ankle surgery in the US Medicare population. Foot & ankle international. 2014 Apr;35(4):334-40.
[6] Tait M BJ, Lewis D, Gaston G, Loeffler B. Comparison of Early Outcomes and Complications of Scaphoid Excision and Capitolunate Arthrodesis with Screws versus Staples. American Association for Hand Surgery; January 10-14, 2017; Waikoloa, HI, USA.
DSEM/TRM/1217/0983